Description
Naleya Genomik Indonesia, a joint venture with BGI Genomics, stands as a beacon for health advancement in Indonesia. Committed to “Omics for Indonesia”, we offer high-quality, affordable, accessible genomic testing for all. Our cutting-edge Naleya Genomics Lab, powered by BGI technology, provides efficient DNA-based screenings, including NIPT, newborn disease screening, lifestyle genomics test, and early cancer risk detection.
